Academic Journal

AN UPDATED REVIEW OF STEALTH LIPOSOMES AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY

التفاصيل البيبلوغرافية
العنوان: AN UPDATED REVIEW OF STEALTH LIPOSOMES AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY
المؤلفون: SIVADASAN, DURGARAMANI
المصدر: International Journal of Applied Pharmaceutics; Vol 16, Issue 3 (May-Jun), 2024; 22-36 ; 0975-7058
بيانات النشر: Innovare Academic Sciences Pvt. Ltd.
سنة النشر: 2024
المجموعة: Innovare Academic Sciences: E-Journals
مصطلحات موضوعية: Liposomes, Stealth liposomes, Cancer, PEGylation, Targeted delivery, Enhanced permeation and retention effect
الوصف: Liposomes have been the delivery of choice for the cancer targeting therapy for the last few decades. Since the 1990s, the development of sterically stabilized (stealth) liposomes has garnered interest for their long circulating half-life. PEGylated (Polyethylene Glycol) liposomes are most extensively studied for delivering cancer therapeutics in a sustained manner. Stealth liposomes are having a less intrinsic toxicity with higher efficacy in cancer treatment. There are numerous clinical trials on the liposomes in tackling cancer is evident for the better outcome of the delivery system. Stealth liposomes are extensively studied for their improved circulation time and better pharmacokinetic profile in cancer treatment. The steric hindrance of the stealth liposomes bypasses the reticuloendothelial system clearance. Further the ligands conjugation in the surface of the liposomes able to achieve better target to the cancer cells. The vascularization nature of the cancerous cells is readily making the liposomal delivery of the cancer drugs accumulate in the cancerous cells rather than healthy cells. There is an utmost need to understand the possible mechanism of stealth liposomes and the basic science behind the development of liposomal delivery system in advancing the cancer treatment with less toxicity. The present review addresses the various modalities of the liposomal development, liposome characterization, mechanism of PEGylated liposomes, the advancements and results of the liposomes in the treatment of various diseases, and the clinical trials and regulatory considerations of liposomal drug delivery system.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf; text/html
اللغة: English
Relation: https://journals.innovareacademics.in/index.php/ijap/article/view/50601/30060; https://journals.innovareacademics.in/index.php/ijap/article/view/50601/30106; https://journals.innovareacademics.in/index.php/ijap/article/view/50601
الاتاحة: https://journals.innovareacademics.in/index.php/ijap/article/view/50601
Rights: Copyright (c) 2024 DURGARAMANI SIVADASAN ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.869C2773
قاعدة البيانات: BASE